Ebixa

Ebixa is an effective, safe and well tolerated therapy, that helps overcome the everyday challenges in Alzheimer’s disease, easing the lives of both patients and their carers. Ebixa is indicated for the treatment of moderate to severe Alzheimer’s disease. Ebixa is a specific, uncompetitive NMDA-receptor antagonist, with a novel mechanism of action that targets the glutamatergic signalling in the brain.

Contact Details: H. Lundbeck A/S Ottiliavej 9 Copenhagen Valby DK 2500 Denmark Tel: 45 36 30 13 11 Fax: 45 36 30 19 40 Email: information@lundbeck.com WWW: www.ebixa.com/

Press Releases on Ebixa:
Diagnosis and Drug Treatment of Alzheimer's Disease in China is Low and Will Remain Low Through 2012	3rd December, 2008	Decision Resources	WALTHAM, Mass., Dec. 3 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the diagnosis
An introduction to the key CNS Disorders	1st January, 1970	Dailyupdates	An introduction to the key CNS Disorders Alzheimer's Disease: Over the last 3 years, the value of the Alzheimer's disease market has grown by an average of 19% per year. Growth has been
The CNS Market Outlook to 2009	1st January, 1970	Datamonitor	The CNS Market Outlook to 2009 The management report 'The CNS Market Outlook to 2009' provides in-depth analysis of the current growth opportunities, threats, leading players and their future

BioNews Results for Ebixa:
Institute for Quality and Efficiency in Health Care: Benefit of memantine in the treatment of Alzheimer's disease not proven	NewsRX:  Nov 14 2009 5:14AM Matching: ebixa
Lundbeck posts steady set of financials for third quarter	Pharma Times:  Nov 5 2009 12:53AM Matching: ebixa
Third quarter 2009 report - Lundbeck records 20% growth, driven by Lundbeck Inc. and key products	Therapeutics Daily:  Nov 3 2009 11:22AM Matching: ebixa
No scientific proof that patients with Alzheimer's disease benefit from drugs containing the agent memantine	News-Medical.Net:  Oct 29 2009 5:33AM Matching: ebixa
Benefit Of Memantine In The Treatment Of Alzheimer's Disease Not Proven	Red Orbit:  Oct 28 2009 11:47PM Matching: ebixa
Promote your company here: BioNewsCast - Press Release Distribution	→View more Ebixa news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 292 times since April 2007, the link to the organisation's website has been followed 70 times

Search for more companies in Copenhagen

Search for more companies in Valby

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Ebixa